Product Information

ARNUITY ELLIPTA 50 MCG INH is a brand product labeled by GlaxoSmithKline LLC, priced at $6.6459 per EA under NDC 00173088810. Its NADAC has been published 387 times since Jun 19, 2019.

FDA first approved this application on Aug 20, 2014.

ARNUITY ELLIPTA 50 MCG INH

fluticasone furoate
$6.6459per EA

Strength

50 ug/1

NDC

00173088810

Classification

Brand

Dosage Form

POWDER

Route

RESPIRATORY (INHALATION)

Effective Date

10/21/2026

Active Ingredients

FLUTICASONE FUROATE

Approval Type

New Drug (NDA)

FDA Application

NDA205625

FDA Approved

8/20/2014

On Market Since

5/17/2018

Pharmacological Classes

Corticosteroid Hormone Receptor Agonists
Corticosteroid

Price Statistics

The NADAC for ARNUITY ELLIPTA 50 MCG INH has been published 387 times since Jun 19, 2019, and over the history we have for it it has risen 20.0%. The table below summarizes its recorded NADAC range and movement.

Current price$6.6459 per EA
All-time high$6.7215 (Apr 10, 2024)
All-time low$5.5399 (Jun 19, 2019)
52-week high$6.6528
52-week low$6.6434
Median price$6.6440
Average price$6.2859
Largest weekly change+4.9% (Jul 13, 2022)
Weeks tracked387
Tracking sinceJun 19, 2019

Price History

1W

0.0%

1M

-0.0%

3M

+0.0%

6M

+0.0%

1Y

-0.1%

3Y

-1.1%

5Y

+12.6%

All

+20.0%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 36% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 36%

1 alternative • Same active ingredient

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ARNUITY ELLIPTA 50 MCG INH?

The current National Average Drug Acquisition Cost (NADAC) for ARNUITY ELLIPTA 50 MCG INH, manufactured by GlaxoSmithKline LLC, is $6.6459 per EA (NDC 00173088810), effective Nov 11, 2026.

How has the price of ARNUITY ELLIPTA 50 MCG INH changed over time?

Over the history we have for it, the NADAC for ARNUITY ELLIPTA 50 MCG INH has risen 20.0%. It has been tracked across 387 weekly CMS publications since Jun 19, 2019.

What are the highest and lowest recorded NADAC prices for ARNUITY ELLIPTA 50 MCG INH?

Since Jun 19, 2019, the NADAC for ARNUITY ELLIPTA 50 MCG INH has ranged from a low of $5.5399 (Jun 19, 2019) to a high of $6.7215 (Apr 10, 2024), with a median of $6.6440 per EA.

Are there cheaper alternatives to ARNUITY ELLIPTA 50 MCG INH?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FLUTICASONE ELLIPTA 50 MCG INH, is $4.2461 per EA — about 36% below ARNUITY ELLIPTA 50 MCG INH.

Who manufactures ARNUITY ELLIPTA 50 MCG INH?

ARNUITY ELLIPTA 50 MCG INH (NDC 00173088810) is labeled by GlaxoSmithKline LLC, and CMS classifies it as a brand product.